ITDCEM.BO(ITDCEM.BO)
ITDCEM.BO
No analyst ratings available
No analyst price targets available for ITDCEM.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $123.59B | $155.29B | $185.74B |
| Low | $115.35B | $144.94B | $173.36B |
| High | $130.04B | $163.40B | $195.44B |
| EBITDA Avg | $14.71B | $19.19B | $23.50B |
| Low | $14.34B | $17.99B | $22.01B |
| High | $15.08B | $20.13B | $24.67B |
| EBIT Avg | $12.35B | $16.01B | $19.40B |
| Low | $11.98B | $14.81B | $17.91B |
| High | $12.72B | $16.95B | $20.57B |
| Net Income Avg | $7.33B | $9.96B | $12.40B |
| Low | $7.06B | $9.10B | $11.32B |
| High | $7.60B | $10.63B | $13.24B |
| EPS Avg | $42.67 | $57.97 | $72.17 |
| Low | $41.12 | $52.94 | $65.91 |
| High | $44.21 | $61.90 | $77.06 |
| Analysts (Rev / EPS) | 3 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $24.25B | $32.01B | $37.78B |
| Low | $24.25B | $32.01B | $37.78B |
| High | $24.25B | $32.01B | $37.78B |
| EBITDA Avg | $2.76B | $3.90B | $4.63B |
| Low | $2.76B | $3.90B | $4.63B |
| High | $2.76B | $3.90B | $4.63B |
| EBIT Avg | $2.30B | $3.40B | $4.07B |
| Low | $2.30B | $3.40B | $4.07B |
| High | $2.30B | $3.40B | $4.07B |
| Net Income Avg | $1.27B | $2.06B | $2.54B |
| Low | $1.27B | $2.06B | $2.54B |
| High | $1.27B | $2.06B | $2.54B |
| EPS Avg | $7.40 | $12.00 | $14.80 |
| Low | $7.40 | $12.00 | $14.80 |
| High | $7.40 | $12.00 | $14.80 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |